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Pannexins (Panxs) are a family of single-membrane, large-pore ion, and metabolite
permeable channels. Of the three Panx proteins, Panx1 has beenmost extensively studied,
and has recently emerged as an exciting, clinically relevant target in many physiological and
pathophysiological settings.This channel is widely expressed across various cell and tissue
types; however its links to precise signaling pathways are largely unknown. Herewe review
the current literature surrounding presently identiﬁed Panx1–protein interactions, a critical
ﬁrst step to unraveling the Panx1 signalome. First we elucidate the reported associations
of Panx1 with other ion channels, receptors, and channel signaling complexes. Further,
we highlight recently identiﬁed Panx1–cytoskeleton interactions. Finally, we discuss the
implications of these protein–protein interactions for Panx1 function in various cell and
tissue types, and identify key outstanding questions arising from this work.
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WHAT IS THE VALUE OF UNRAVELING THE PANX1
SIGNALOME?
Panx1 forms large pore channels permeable to ions and small
molecules, and is a clinically relevant protein in inﬂammatory con-
ditions (Kanneganti et al., 2007; Silverman et al., 2009; Gulbransen
et al., 2012; Diezmos et al., 2013), stroke (Thompson et al., 2006;
Bargiotas et al., 2011; Bargiotas et al., 2012; Dvoriantchikova et al.,
2012), and cancer (Lai et al., 2007; Cowan et al., 2012; Penuela
et al., 2012). Panx1 is ubiquitously found in many cell and tissue
types throughout the body, while Panx2 and Panx3 exhibit slightly
more restricted organ and tissue expression patterns. Because of
its widespread distribution, future attempts to develop Panx1-
based therapeutic strategies will optimally incorporate tissue/cell
type speciﬁcity to minimize side effects. Knowledge of the sig-
naling pathways in which Panx1 participates, more precisely, its
unique cell- and tissue-speciﬁc protein interaction partners, will
be important for the development of such targeted therapeutic
strategies. Thus, not only will unraveling the web of the Panx1
signalome be key for understanding the depth and breadth of its
tissue and cell-speciﬁc functions, it will also be critically important
for Panx1-based drug development.
PANX1 PERSPECTIVES, THEN AND NOW
Panx1 was cloned in 1998, and the pannexin family was ﬁrst
described as putative gap junction proteins in 2000 (Panchin
et al., 2000) based on their homology to innexins, the inverte-
brate gap-junction forming proteins. Of the three Panx family
members, Panx1 has been the primary focus of research. A large
body of work has developed the current consensus that Panx1
forms single membrane channels (recently reviewed MacVicar
and Thompson, 2009; Sosinsky et al., 2011). Individual four-
pass transmembrane domain Panx1 subunits come together as
hexamers. Panx1 channels appear to be relatively non-selective,
permitting the passage of small ions and molecules up to one
kilodalton in size. Panx1 is perhaps most well-known for its
role in facilitating ATP release from a variety of cell types under
both physiological and pathophysiological contexts, by several
mechanisms of activation (recently reviewed Sandilos and Bayliss,
2012).
There are still signiﬁcant gaps in the knowledge of the molecu-
lar mechanisms regulating Panx1 function and its downstream
effects. Since its discovery, only a handful of studies have
captured small snapshots of the Panx1 interactome. Here we
unite these somewhat disparate pieces in order to develop a
clearer picture of the cellular signaling network of Panx1. We
also highlight data from our recent study that included the
ﬁrst unbiased proteomics analysis of Panx1 interacting pro-
teins (Wicki-Stordeur and Swayne, 2013). In this minireview,
we have grouped these interacting proteins into two major
categories: (1) ion channels, receptors, and their signaling com-
plexes and (2) cytoskeletal proteins (summarized in Table 1;
Figure 1).
ION CHANNELS, RECEPTORS, AND THEIR SIGNALING
COMPLEXES
PANX1–PANNEXIN INTERACTIONS
An early starting point was othermembers of the Pannexin protein
family (Bruzzone et al., 2005). The initial impetus for investiga-
tion into Panx–Panx interactions likely arose from a rich literature
detailing the intermixing of connexins (reviewed in Koval, 2006),
the vertebrate gap junction protein family. Connexins share struc-
tural similarity to pannexins, but no sequence similarity. The ﬁrst
identiﬁed Panx1 binding protein was its family member, Panx2
(Bruzzone et al., 2005).
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Table 1 | Summary of Panx1 protein interaction partners, supporting evidence, functional significance, and relevant references.
Interactor Evidence Function Reference
Ion channels and receptors (and signaling complexes)
Pannexin 2 (Panx2) MYC IPs (OE)
Functional coupling (OE)
Panx1 and Panx2 IPs (OE)
Puriﬁed channels (OE)
Modiﬁcation of Panx1 channel
function
Panx2 trafﬁcking and localization
Bruzzone et al. (2003, 2005),
Penuela et al. (2009),
Ambrosi et al. (2010)
Pannexin 3 (Panx3) Co-loc (OE and Endg) Unknown Penuela et al. (2009)
Panx1 and Panx3 IPs (OE)
Purinergic receptor, P2X, ligand-gated ion
channel 7 (P2X7 receptor)
MYC IP (OE)
Functional coupling (OE)
EGFP IP (OE)
Panx1 and P2X7 IPs
P2X7 IP
Panx1 IP
MYC and FLAG IPs (OE)
Panx1 forms the large pore of
the P2X7 receptor complex
known as the “death pore”
Inﬂammasome activation
Pelegrin and Surprenant (2006), Locovei
et al. (2007), Iglesias et al. (2008),
Silverman et al. (2009), Poornima et al.
(2012), Xu et al. (2012), Kanjanamekanant
et al. (2013), Wang et al. (2013)
Inﬂammasome (associated with P2X7) Inﬂammasome activation
NOD-like receptor family, pyrin-domain
containing 1 (NLRP1)
Panx1 IP (NLRP and/or cell-type
dependent)
Silverman et al. (2009)
NOD-like receptor family, pyrin-domain
containing 2 (NLRP2)
NLRP2 IP Minkiewicz et al. (2013)
NOD-like receptor family, pyrin-domain
containing 2 (NLRP3)
FLAG and HA IPs Wang et al. (2013)
Apoptosis-associated speck-like protein
containing CARD (ASC)
Panx1 and ASC IP
ASC IP
Silverman et al. (2009),
Minkiewicz et al. (2013)
X-linked inhibitor of apoptosis (XIAP) Panx1 IP Silverman et al. (2009)
Caspase 1 (Casp1) Panx1 IP Silverman et al. (2009)
Caspase 11 (Casp11) Panx1 IP Silverman et al. (2009)
Purinergic receptor, P2X, ligand-gated ion
channel 4 (P2X4 receptor)
P2X4 IP ATP-induced ROS production Hung et al. (2013)
Voltage-gated potassium channel subunit
beta-3 (Kcnab3)
B2H and co-loc
HA and MYC IPs
Modulating Panx1 redox
sensitivity and Panx1
inactivation
Bunse et al. (2005, 2009)
α-1D adrenergic receptor (Adra1d) Panx1 and Adra1d IPs Panx1 activation coupled to
adrenoreceptor function
Billaud et al. (2011)
Possible role in blood pressure
regulation
Cytoskeletal Proteins
Actin Panx1 (OE) IP and BA
Panx1 IP and co-loc (OE)
Panx1 trafﬁcking and
stabilization
Bhalla-Gehi et al. (2010),
Wicki-Stordeur and Swayne (2013)
Actin-related protein 3 (Arp3) GFP IP and LC-MS/MS,
Panx1 IP and co-loc (OE)
Unknown Wicki-Stordeur and Swayne (2013)
B2H, bacterial two-hybrid; BA, binding assay; Co-loc, Co-localization; Endg, endogenous; IP, immunoprecipitation; OE, overexpressed; LC-MS/MS, high performance
liquid chromatography coupled to tandem mass spectrometry analysis.
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FIGURE 1 |The Panx1 interactome. A diagram generated using Ingenuity
Pathways Analysis [IPA; Ingenuity Systems (Qiagen), Redwood City, CA,
USA] representing a curated list of the Panx1 interacting proteins, and the
subsequent IPA-derived interaction networks of these interactors (excluding
actin). The thick line between Panx1 and actin represents a direct
interaction. The dotted line between Panx1 and SFKs indicates a likely link
between the two proteins, however, no physical interaction data is yet
available.
Panx2 is a much larger protein that Panx1, owing to its excep-
tionally longer C-terminus. It is particularly enriched in the
brain (Baranova et al., 2004). The discovery of this interaction by
Bruzzone et al. (2005) arose subsequent to an earlier observation
by the same group, that depolarization-evoked currents in Xeno-
pus oocytes injected with RNA for both Panx1 and Panx2 were
signiﬁcantly smaller and had modiﬁed gating kinetics in com-
parison with currents from Xenopus oocytes injected with Panx1
RNA alone (Bruzzone et al., 2003). The RNA encoding Panx2 itself
did not lead to a depolarization-activated current. The authors
proposed that Panx1/Panx2 heteromerization was the underlying
cause for the difference in depolarization-evoked currents. Their
later discovery of the interaction between epitope-tagged Panx1
and Panx2 supported this hypothesis (Bruzzone et al., 2005).
Key questions arose from these initial ﬁndings. For these ﬁnd-
ings to be physiologically relevant, Panx1 andPanx2must be found
in the same cells, and need to come into close proximity. Whether
Panx1 and Panx2 are found in the same subcellular compartments
is still an open question. To date, several studies have shown that
ectopically and endogenously expressedPanx1 are foundprimarily
at the cell surface, with some reports of intracellular expression.
In contrast, ectopically (Lai et al., 2009; Penuela et al., 2009) and
endogenously (Swayne et al., 2010; Wicki-Stordeur et al., 2013)
expressed Panx2 are largely found primarily in intracellular com-
partments. Whether Panx2 forms functional channels at the cell
membrane is contentious (but see Penuela et al., 2009). Further, if
Panx2 forms functional channels, are they activated in the same
way as Panx1 channels? Does the interaction occur early in the
secretory pathway, and could it impact on the trafﬁcking of Panx1?
Penuela et al. (2009) later demonstrated that co-expression
with Panx1 in HEK293T cells dramatically increased the cell
surface expression of Panx2, measured by cell surface biotiny-
lation and confocal microscopy. In HEK 293T cells ectopically
co-expressing Panx1 and Panx2, the authors conﬁrmed reciprocal
co-precipitation of the twoproteins. Interestingly, immunoprecip-
itationof Panx2 co-precipitates the immature glycosylation species
of Panx1 speciﬁc to the early secretory pathway (gly0 and gly1).
This suggests the proteins are able to interact early in the secretory
pathway, not long after translation. Somewhat paradoxically, the
ability of Panx1 to increase the cell surface expression of Panx2
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suggests that Panx1/Panx2 reaches the plasma membrane. In a
similar set of experiments, this group also demonstrated overlap-
ping distributions of Panx1 and Panx3 using confocal microscopy,
and an interaction by immunoprecipitation. The extent of Panx1
and Panx3 co-precipitation was modulated by the glycosylation
state of Panx1, but the physiological implications of these ﬁndings
have not yet been fully elucidated.
Interestingly, Ambrosi et al. (2010) found that puriﬁed
Panx1/Panx2 heteromeric channels from insect cells were unstable
over time (present at 1 h, but not 24 h post-puriﬁcation). Addi-
tional experiments led the authors to suggest these ﬁndings could
have resulted from size differences between Panx1 and Panx2, as
well as experimentally identiﬁed differences in oligomeric symme-
try (their study suggested that Panx1 forms hexamers while Panx2
forms octamers).
How Panx1 and Panx2 might functionally interact in cells
remains to be determined. In the context of the nervous system, the
distribution of Panx2 appears to change from intracellular to cell
surface during the course of hippocampal neurogenesis (Swayne
et al., 2010), but whether Panx1 and Panx2 have overlapping dis-
tributions in mature neurons is currently unknown. Recent work
investigating the role of Panxs in stroke recovery has demonstrated
that knockout of both Panx1 and Panx2 improves histological and
behavioral outcomes (Bargiotas et al., 2011; Kindo et al., 2011).
Thus elucidation of the functional and physical relationships
between members of the pannexin family will provide us with
both fundamental and clinically relevant information. Although
much progress has been made, there are still many unanswered
questions relating to the crosstalk between Panx glycosylation and
trafﬁcking and the role of the Panx family interactions in this
respect.
P2X7 RECEPTORS
It is perhaps not surprising that the physiological and patho-
physiological roles of pannexins and P2 purinergic receptors are
connected given the former is perhaps best known as an ATP
release channel, and the latter act as receptors for ATP and its
metabolite, ADP. Pelegrin and Surprenant (2006) ﬁrst reported a
physical and functional interaction between overexpressed Panx1
and P2X7 receptors in 2006. The authors also demonstrated that
P2X7 receptor activation in macrophage led to the opening of a
large pore permeable to dye and IL-1β release. Based on their data,
the authors concluded that Panx1 channels formed the large pore
previously ascribed to P2X7 receptors alone. Subsequent work by
Locovei et al. (2007) in the Xenopus oocyte heterologous expres-
sion model further supported this work. They showed that P2X7
receptors formed a non-selective ion channel, but co-expression
with Panx1 was necessary to form a larger channel referred to as
the “death pore.” Poornima et al. (2012) also reported an interac-
tion betweenPanx1 andP2X7 receptors overexpressed inN2a cells.
Recently, Kanjanamekanant et al. (2013) demonstrated an inter-
action between endogenous Panx1 and P2X7 receptor in human
periodontal ligament cells using reciprocal immunoprecipitations,
and found this interaction was strengthened followingmechanical
stress. Interestingly, Xu et al. (2012) observed a functional inter-
action only between Panx1 and the P2X7a receptor splice variant
using dye uptake studies in overexpressing HEK293 cells. It now
appears that such aPanx1-P2X7 receptor complexmay also involve
P2X4 receptor components in some cell types, asHung et al. (2013)
recently co-precipitated these three proteins from immortalized
gingival epithelial cells.
Extending on the earlier ﬁndings by Pelegrin and colleagues, in
the J774 monocyte macrophage cell line derived from a BALB/C
mouse tumor, Iglesias et al. (2008) showed that Panx1 activation
was tightly coupled to P2X7 receptor activation via a Panx1/P2X7
receptor complex involving a Src family tyrosine kinase (SFK).
This group demonstrated interaction between the endogenously
expressed proteins and were able to block the functional inter-
action with a membrane permanent TAT-P2X7 peptide targeting
the SH3 domain of the P2X7 receptor. Interestingly, Weilinger
et al. (2012) have further linked SFKs more directly to Panx1
function using a Panx1 C-terminal competitive peptide strat-
egy; however a physical interaction between the two proteins has
not yet been illustrated. Alberto et al. (2013) observed conﬂict-
ing ﬁndings with respect to the Panx1-P2X7 receptor coupling;
in primary mouse and rat peritoneal macrophage cultures, RNAi
targeting Panx1, as well as probenecid and carbenoxolone treat-
ment to block Panx1, had no effect on ATP-induced P2X7
currents. It should be noted that these two studies used substan-
tially different recording solutions. More importantly, there are
likely substantial differences arising from the use of two differ-
ent macrophage models. Macrophages are found in all tissues.
As a result of their extreme inherent plasticity, these distinct
tissue-subsets have a high level of diversity in terms of gene
expression and functional capabilities (Wynn et al., 2013). Even
within peritoneal macrophages, it has been recently revealed that
there are two physical, functionally and developmentally distinct
subsets (Ghosn et al., 2010). Thus, the Panx1/P2X7 receptor rela-
tionship in macrophages is likely state- and subset-dependent.
Moreover microglia, the macrophage-like resident immune cells
of the brain, also possess a P2X7-Panx1 functional unit. Rigato
et al. (2012) recently observed that microglial proliferation is
dependent on P2X7 receptor and not Panx1, however, initial
microglial activation and/or recruitment may still possess a Panx1
component.
The inﬂammasome, P2X7 receptors, and Panx1 in cytokine
activation and immune cell recruitment
Interestingly, Panx1 has recently been linked to the inﬂamma-
some, a large cytoplasmic complex involved in cytokine activation
and immune cell recruitment (Martinon et al., 2002, 2009). P2X7
receptors and Panx1 have been reported to be associated with
inﬂammasomes in a variety of cell types (Silverman et al., 2009).
As critical components of the inﬂammasome, Nod-like recep-
tor proteins (NLRPs) link the detection of “danger signals” [or
danger associated molecular pattern molecules (DAMP)], arising
under scenarios such as metabolic stress, to proteolytic activation
of the pro-inﬂammatory cytokines IL-1β and IL-18. Other key
complex proteins include the adaptor protein ASC (Apoptosis-
associated speck-like protein containing a CARD), and the inﬂam-
matory caspases-1 and -11. While P2X7 receptors are established
inﬂammasome components, a recent report (Silverman et al.,
2009) in cortical neurons revealed the potential involvement of
Panx1. Silverman and colleagues immunoprecipitated Panx1 from
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cultured primary cortical neurons. Major components of the
neuronal inﬂammasome including the P2X7 receptor, NLRP1,
ASC, caspase-1, caspase-11, and X-linked inhibitor of apopto-
sis protein (XIAP) co-precipitated with Panx1. Reciprocally, ASC
co-precipitated Panx1 as well as NLRP1, caspase-1, caspase-11,
and XIAP. The authors further showed that elevating extracellular
potassium above the normal resting range opened Panx1 chan-
nels leading to caspase-1 activation, and that this was sensitive to
the Panx1 blocker probenecid. They determined that potassium-
dependent activation of Panx1 was independent of changes in
the membrane potential, which suggested that stimulation of
inﬂammasome signaling was mediated by an allosteric effect of
potassium binding to Panx1.
Minkiewicz et al. (2013) recently described a novel inﬂam-
masome in human astrocytes. They detected NLRP2 protein in
human astrocytes and investigated the putative involvement of
Panx1 in an NLRP2-based astrocytic inﬂammasome. Immuno-
precipitation of NLRP2 from human primary astrocyte cul-
tures co-precipitated Panx1, ASC, caspase-1, and P2X7 receptor.
Reciprocally Panx1, P2X7 receptor, NLRP2, and caspase-1 co-
precipitated with ASC. A more recent study (Wang et al., 2013)
showed that while overexpressed Panx1 and NLRP3, or Panx1 and
P2X7 receptors co-precipitated, overexpressed ASC and Panx1 did
not interact in HEK293T cells. Interestingly, there were no deﬁ-
ciencies in NLRP3-inﬂammasome activation in macrophage of
Panx1 knock-out mice (Qu et al., 2011; Wang et al., 2013; but see,
Hung et al., 2013).
Gulbrandsen and colleagues conﬁrmed in vivo Panx1 involve-
ment in the NLRP3 inﬂammasome. They found that blocking
Panx1 channels in enteric neurons ameliorates some of the effects
of experimental colitis, including neuronal death (Gulbransen
et al., 2012). Further, enteric neuronal death was dependent on
P2X7 receptor, ASC, and caspase function, but not that of NLRP3,
implying that a separate Panx1-inﬂammasome complex may be
involved. Therefore, whether Panx1 is universally involved in
inﬂammasome complexes may be characterized by cell type spe-
ciﬁc NLRP expression and utilization. Furthermore, the precise
functional role of the physical association between Panx1 and
inﬂammasome components remains to be determined.
POTASSIUM CHANNEL AUXILIARY SUBUNIT Kvβ3
One of the initial Panx1 interactome studies was performed by
Bunse et al. (2005). They employed an E. coli two-hybrid system
to search for potential Panx1 interactors. This study identi-
ﬁed the potassium channel accessory subunit, Kvβ3 (Kcnab3)
as a putative interactor with the Panx1 C-terminus. Kvβ3 inter-
acts with the shaker related voltage-gated potassium channels
Kv1.1, 1.3, 1.5, and 1.6 to modify voltage-dependent activa-
tion, and inactivation kinetics (Leicher et al., 1998; Bahring et al.,
2004; Tipparaju et al., 2012). A follow-up study conﬁrmed the
Panx1-Kvβ3 interaction in a double-overexpression system by co-
precipitation for the tagged proteins. An additional functional
investigation indicated that ectopically expressed Panx1 currents
became somewhat desensitized to redox- and pharmacological-
based inhibition upon co-expression of Kvβ3 in oocytes (Bunse
et al., 2009). The authors postulated that Kvβ3 is important for
regulating Panx1 channel function by modulating its sensitivity
to redox potentials. Bunse et al. (2011) further conﬁrmed redox
modulation of Panx1 activity, however, the molecular mecha-
nisms underlying this sensitivity remain unknown. This will likely
prove to be important in pathological contexts such as stroke and
hypoxia, where redox signaling plays an important role (reviewed
in Valko et al., 2007).
α1D-ADRENORECEPTOR
Because of the established role of Panx1 in the release of ATP,
a signaling molecule important for vasoconstriction, Billaud et al.
(2011) performed Panx1 immunoprecipitations from thoracodor-
sal resistance arteries to examine its role in vascular smoothmuscle
cell communication. They identiﬁed an interaction between
endogenous Panx1 and the α1D-adrenoreceptor. Further, they
noted that ATP release via Panx1 was necessary to facilitate
phenylephrine-evoked α1D-adrenoreceptor-mediated vessel con-
striction. Moreover, results from a HEK293 expression system
indicated a Panx1-dependent component toATP release evoked by
α1D-adrenoreceptor activation (Sumi et al., 2010). Taken together,
these studies indicate a mechanism for Panx1 activation down-
stream of adrenoreceptor stimulation, and imply a role for this
channel in systemic blood pressure regulation.
CYTOSKELETAL PROTEINS
Perhapsunsurprisingly, due to its knownmechanosensitivenature,
Panx1 has recently been found to associate with cytoskeletal
proteins. Bhalla-Gehi et al. (2010) initially noted a role of the actin-
based microﬁlament cytoskeleton in the cell-surface trafﬁcking
and stabilization of Panx1. Further study revealed an interac-
tion between ectopically expressed Panx1 and actin. Interestingly,
in vitro binding assays with puriﬁed proteins revealed the Panx1
C-terminus as the region responsible for the direct interaction.
More recently, our group conﬁrmed this Panx1-actin associa-
tion with endogenous Panx1 immunoprecipitations from a neu-
roblastoma cell line (Wicki-Stordeur and Swayne, 2013). More-
over, immunoﬂuorescence and confocal microscopy illustrated
co-localization of Panx1-EGFP with actin.
Our study also uncovered several novel Panx1 interactors. We
performed immunoprecipitations from Panx1-EGFP expressing
cells, coupled to mass spectrometry-based identiﬁcation. From
these, a putative association of Panx1 with actin-related pro-
tein 3 (Arp3) was revealed. This interaction was conﬁrmed
through endogenous Panx1 co-precipitations, and co-localization
by immunoﬂuorescence. Arp3 is a component of the large Arp2/3
actin-regulating complex involved in nucleation and branching
of microﬁlaments (reviewed in Firat-Karalar and Welch, 2011).
Because of its key role in controlling the dynamic actin cytoskele-
ton, the Arp2/3 complex is key in several cellular processes
dependent on actin remodeling, such as ﬁlopodia (Korobova and
Svitkina, 2008; Spillane et al., 2011) and lamellipodia (Ingerman
et al., 2013) formation, cell migration (Sawa et al., 2003; Schae-
fer et al., 2008), and neurite outgrowth (Schaefer et al., 2008;
Firat-Karalar et al., 2011).
Using gene ontology (GO) analysis we determined that 10%
of the mass spectrometry-identiﬁed putative Panx1 interactors in
neuroblastoma cells fell under a cytoskeleton classiﬁcation. While
most of these have yet to be validated, the large proportion of
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cytoskeletal interactors implies a signiﬁcant role for the cytoskele-
ton in regulation of Panx1 trafﬁcking and function. Potentially
further connecting Panx1 with the cytoskeleton and other ion
channels, a novel interaction between stomatin and Panx1 has also
recently been identiﬁed that inhibits Panx1 currents (Zhan et al.,
2012). Much work will clearly be needed to begin to untangle the
complexities of emerging Panx1 nexus.
CONCLUDING REMARKS
The Panx1 interactome is beginning to emerge, however,many key
questions remain unanswered. For instance, which of the Panx1
interactions are direct, and which occur indirectly through other
bridging proteins? At present, the Panx1-actin relationship stands
alone as the only proven direct interaction. The functional signif-
icance of many of these interactions is also currently unknown.
Moreover, questions arise regarding the tissue and cell-type speci-
ﬁcity of these interactions. For example, the Panx1-inﬂammasome
connection not only seems to depend on which NLRP is forming
the complex, but also on the cell type in question. Finally, little is
understood regarding alterations to the Panx1 interactome under
pathophysiological conditions, such as stroke. In order to ﬁll such
knowledge gaps in our understanding of the role of Panx1 in both
physiological and pathophysiological settings, the Panx1 interac-
tome must be more fully elucidated and understood. In this way
we will uncover key molecular players involved in Panx1 regula-
tion and function, and thus be able to consider Panx1 as a viable
therapeutic target within clinical settings.
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